Trial Profile
Effects of agomelatine in patients with major depression.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jan 2015
Price :
$35
*
At a glance
- Drugs Agomelatine (Primary)
- Indications Major depressive disorder
- Focus Pharmacodynamics; Therapeutic Use
- 30 Jan 2015 New trial record